Besonderhede van voorbeeld: -8209463454793203377

English

With improved understanding of the nature of the BCR-ABL protein and its action as a tyrosine kinase, targeted therapies (the first of which was imatinib) that specifically inhibit the activity of the BCR-ABL protein have been developed.

Chinese

基于对BCR-ABL蛋白以及酪氨酸残基的研究,靶向治疗(首先被采用的是伊马替尼)则着重于特别地抑制BCR-ABL蛋白的活动。